These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7900514)

  • 1. Pulmonary edema in association with an intravenous infusion of sulprostone.
    Stock A; Jones R; Chung T; Fung HY
    Acta Obstet Gynecol Scand; 1995 Feb; 74(2):156-8. PubMed ID: 7900514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute myocardial infarct following sulprostone administration].
    Feenstra J; Borst F; Huige MC; Oei SG; Stricker BH
    Ned Tijdschr Geneeskd; 1998 Jan; 142(4):192-5. PubMed ID: 9557026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative use of analogs of prostaglandin by intravenous or vaginal administration in termination of pregnancy].
    Poulain P; Blanchot J; Roze JM; Babatasi S; Grall JY
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(2):223-7. PubMed ID: 2182703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of sulprostone for induction of preoperative cervical dilation or uterine evacuation: a comparison among the effects of different treatment schedules.
    Fruzzetti F; Melis GB; Strigini F; Vettori C; Ricci C; Fioretti P
    Obstet Gynecol; 1988 Nov; 72(5):704-8. PubMed ID: 3173921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulprostone for pregnancy termination in women with severe (pre-) eclampsia.
    van Gemund N; de Boer MA; van Selm M; Scherjon SA; Kanhai HH
    Hypertens Pregnancy; 2002; 21(2):115-22. PubMed ID: 12175439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Termination of normal and pathological pregnancy with Sulprostone.
    Fischer Z; Chwalisz K; Michałkiewicz W
    Acta Chir Hung; 1986; 27(3):151-6. PubMed ID: 3825407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low dose sulprostone for termination of second and third trimester pregnancies.
    de Boer MA; van Gemund N; Scherjon SA; Kanhai HH
    Eur J Obstet Gynecol Reprod Biol; 2001 Dec; 99(2):244-8. PubMed ID: 11788180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulprostone, a synthetic PGE2 analogue in first trimester abortion. Clinical efficacy and influence on serum progesterone of different single doses.
    Larsson B; Jonasson A; Carlström K
    Gynecol Obstet Invest; 1990; 29(1):10-2. PubMed ID: 2351329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of preinduction by mifepristone on therapeutic abortions of the second and third trimesters induced by intravenous sulprostone].
    D'Ercole C; Blanc B; Boubli L; Bautrant E; Nadal F; Eyraud B
    Rev Fr Gynecol Obstet; 1992 May; 87(5):277-80. PubMed ID: 1626173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous sulprostone infusion in the treatment of retained placenta.
    Stefanovic V; Paavonen J; Loukovaara M; Halmesmäki E; Ahonen J; Tikkanen M
    Acta Obstet Gynecol Scand; 2013 Apr; 92(4):426-32. PubMed ID: 22862433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current method for pregnancy termination with prostaglandins in the 2nd and 3rd trimester].
    Winkler M; Rath W
    Z Geburtshilfe Neonatol; 1997; 201(2):39-43. PubMed ID: 9235279
    [No Abstract]   [Full Text] [Related]  

  • 12. Low dose synthetic prostaglandin E2: always safe for pregnancy termination?
    Jeurissen SE; Harinck HI; Oepkes D
    Lancet; 2004 Sep 11-17; 364(9438):1010. PubMed ID: 15364195
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of sulprostone for cervical dilation in nulliparas during 1st trimester abortions].
    Giannone R; Poli M; Bernardi F; Ferrari E
    Minerva Ginecol; 1988 Sep; 40(9):553-5. PubMed ID: 3222011
    [No Abstract]   [Full Text] [Related]  

  • 14. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.
    Ramsey PS; Savage K; Lincoln T; Owen J
    Obstet Gynecol; 2004 Jul; 104(1):138-45. PubMed ID: 15229013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gameprost, sulproston and dinoproston for induced abortion in the 15th-24th week of pregnancy].
    Kamali P; Hohmann M; Herrero J; Künzel W
    Zentralbl Gynakol; 1998; 120(6):293-300. PubMed ID: 9659700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Circulatory arrest following sulprostone administration in postpartum hemorrhage].
    Beerendonk CC; Massuger LF; Lucassen AM; Lerou JG; van den Berg PP
    Ned Tijdschr Geneeskd; 1998 Jan; 142(4):195-7. PubMed ID: 9557027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardio-circulatory arrest with mifepristone sulprostone combination for pregnancy interruption].
    Sorbette F; Delay M; Genestal M; Jorda MF; Carrie D; Montastruc JL; Catala B; Bernadet P
    Therapie; 1991; 46(5):387-9. PubMed ID: 1754984
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pregnancy termination in the second trimester with vaginally administered dinoprostone followed by intravenous sulprostone, for the indication 'foetal congenital defects'; results of a retrospective study].
    Willems FE
    Ned Tijdschr Geneeskd; 2004 Aug; 148(33):1656-7; author reply 1657. PubMed ID: 15455517
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pregnancy termination in the 2d and 3d trimester with prostaglandins depending on the cervix status].
    Rath W; Gerland W; Osmers R
    Zentralbl Gynakol; 1991; 113(9):519-26. PubMed ID: 1927141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous sulprostone and uterine scarring based upon 22 cases of therapeutic abortion during 2nd and 3rd trimesters of pregnancy.
    Marpeau L; Percque M; Larue L; Guettier X; Jault T; Pigne A; Barrat J
    Eur J Obstet Gynecol Reprod Biol; 1993 Jul; 50(2):105-8. PubMed ID: 8405637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.